Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

AGNGvsPBPHETF Comparison

ETF 1
AGNG

Global X Aging Population ETF

This fund is part of
New Consumers & Focus
+1.22%
VS
ETF 2
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of
DM Large & Mid Cap
+2.01%

Global X Aging Population ETF (AGNG) belongs to the New Consumers & Focus segment. Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is part of the DM Large & Mid Cap segment. AGNG's top 3 sector exposures are Healthcare, Finance and Technology. In contrast, PBPH's top sector exposures are Healthcare,  AGNG is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.13% for PBPH. AGNG is up 4.95% year-to-date (YTD) with +$13M in YTD flows. PBPH performs better with 8.7% YTD performance, and +$933M in YTD flows. Run a side-by-side ETF comparison of AGNG and PBPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

AGNG vs PBPH performance and flow charts

Performance

-2.00.02.04.0%Jun 30Jul 7Jul 14Jul 21Jul 28

Cumulative Flows

0 M20 M40 M60 M80 M100 MJun 30Jul 7Jul 14Jul 21Jul 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/30/2026
1M3MYTD1Y3Y5Y
Perf.
AGNG
PBPH
+4.11%+1.04%
+7.07%+9.56%
+4.95%+8.70%
+16.31%n/a
+37.15%n/a
+28.43%n/a
Flows
AGNG
PBPH
-+$103M
+$692K+$129M
+$13M+$933M
+$18M-
+$23M-
+$13M-
Volatility and drawdown
3M1Y3Y5Y
Volatility
AGNG
PBPH
+14.86%+18.27%
+13.13%n/a
+12.28%n/a
+13.80%n/a
Max drawdown
AGNG
PBPH
-4.89%-4.94%
-11.18%n/a
-13.73%n/a
-25.40%n/a
Max drawdown duration
AGNG
PBPH
31d20d
151dn/a
323dn/a
1041dn/a
Trading data

Create an account to view trading data

Join for free
AGNG
PBPH
Last sale
7/30/2026 at 7:58 PM
$37.50
$27.06
Previous close
07/30/2026
$37.82
$27.53
Consolidated volume
07/30/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
AGNG
PBPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/30/2026 at 7:58 PM
Live
Closed
AGNG
PBPH
Last price
$37.50
$27.06
1D performance
-0.83%
-1.73%
AuM$87.98 M$960.99 M
E/R0.5%0.13%
Characteristics
AGNG
PBPH
Management strategyPassivePassive
ProviderGlobal XTidal
BenchmarkIndxx Aging Population Thematic IndexBITA Global Pharma and Biotech Select Index
N° of holdings8452
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateMay 9, 2016November 24, 2025
ESGYesNo
Advertisement
Exposure

Countries

AGNG
USA
55.01%
Switzerland
13.28%
Other
31.7%
PBPH
USA
65.6%
Switzerland
10.39%
United Kingdom
7.56%
Other
16.46%

Sectors

AGNG
Healthcare
90.38%
Finance
9.07%
Other
0.55%
PBPH
Healthcare
99.59%
Other
0.41%
Advertisement

Diversification

AGNG

Total weight of top 15 holdings out of 15

47.54%
PBPH

Total weight of top 15 holdings out of 15

75.88%

Top 15 holdings

Data as of June 30, 2026
AGNG
Novo Nordisk A/S
3.84%
Eli Lilly & Co.
3.82%
AbbVie, Inc.
3.57%
Edwards Lifesciences Corp.
3.42%
Welltower, Inc.
3.29%
Johnson & Johnson
3.19%
Merck & Co., Inc.
3.13%
Ventas, Inc.
3.11%
Roche Holding AG
3.05%
Amgen, Inc.
3.01%
Bristol Myers Squibb Co.
2.92%
Stryker Corp.
2.88%
UCB SA
2.81%
AstraZeneca PLC
2.76%
Medtronic Plc
2.73%
PBPH
Eli Lilly & Co.
16.15%
Johnson & Johnson
9.67%
AbbVie, Inc.
6.99%
Merck & Co., Inc.
4.97%
Roche Holding AG
4.52%
Novartis AG
4.43%
AstraZeneca PLC
4.31%
Amgen, Inc.
4.30%
Gilead Sciences, Inc.
3.63%
Novo Nordisk A/S
3.55%
Pfizer Inc.
3.22%
Vertex Pharmaceuticals, Inc.
2.93%
Bristol Myers Squibb Co.
2.77%
GSK Plc
2.26%
Sanofi
2.17%
Frequently asked questions about AGNG and PBPH

How have the AGNG and PBPH ETFs performed in 2026?

As of July 30, 2026, AGNG is up 4.95% year-to-date (YTD), while PBPH has returned 8.7%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: AGNG or PBPH?

Year-to-date, the AGNG ETF saw +$13M in flows, compared to +$933M for PBPH.

Which ETF is bigger: AGNG or PBPH?

As of July 30, 2026, AGNG holds $87.98 M in assets under management (AUM), while PBPH manages $960.99 M.

What sectors do the AGNG and PBPH ETFs invest in?

AGNG leans toward sectors like Healthcare and Finance. Meanwhile, PBPH focuses on Healthcare.

What are the top holdings of the AGNG ETF and PBPH ETF?

AGNG top holdings include Novo Nordisk A/S, Eli Lilly & Co. and AbbVie, Inc.. PBPH holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: AGNG or PBPH?

AGNG holds 84 securities with 47.54% of its assets in the top 15. PBPH has 53 securities and a top 15 weight of 75.88%.

Advertisement
Latest news about AGNG & PBPH
Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up